Take stock of research ethics in human genome editing
Progress in the use of CRISPR–Cas9 for human germline editing highlights some pressing ethical considerations for research on embryos.
Article tools
Zephyr/SPL
This week, Nature publishes the results of experiments that used genome editing to modify the DNA of a human embryo. Kathy Niakan at the Francis Crick Institute in London and her colleagues have used the CRISPR–Cas9 technique to introduce mutations into a gene called OCT4, and show how the gene is required to steer cell fate as a fertilized egg starts to divide and proliferate (N. M. E. Fogarty et al. Nature http://dx.doi.org/10.1038/nature24033; 2017).
No hay comentarios:
Publicar un comentario